Effect of GCS-100, a Polysaccharide Derived from Citrus Pectin, on Lymphoma Cells

Loading... Loading video...

Air date:	Wednesday, September 8, 2010, 1:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 131 * This only includes stats from October 2011 and forward.
Category:	Special
Runtime:	00:55:29
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) invites you to view its monthly lecture series. With the goal of informing the National Cancer Institute (NCI) community about the variety of ongoing research in cancer and complementary and alternative medicine (CAM), NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) has created a monthly lecture series on cancer CAM. These hour long lectures, occurring from 10 a.m. - 11 a.m. on the second Wednesday of each month, will feature a fifty minute presentation on a cancer CAM topic and allow ten minutes for questions. For more information, visit http://www.cancer.gov/cam/news_lectures.html

NLM Title:	Effect of GCS-100, a polysaccharide derived from citrus pectin, on lymphoma cells / Dr. Linda Baum, UCLA School of Medicine.
Author:	Baum, Linda. National Institutes of Health (U.S.),
Publisher:
Subjects:	Apoptosis--drug effects Cell Cycle--drug effects Galectin 3--antagonists & inhibitors Galectin 3--metabolism Lymphoma, Large B-Cell, Diffuse--drug therapy Polysaccharides--pharmacology
Publication Types:	Lecture Webcast
NLM Classification:	WH 525
NLM ID:	101546202
CIT Live ID:	9383
Permanent link:	https://videocast.nih.gov/watch=9383

NIH VideoCasting